Origin of Tick-Borne Lyme Disease Successfully Added to Defense Act
U.S. Representative Chris Smith says we are now “one step closer to finally determining whether the U.S. government’s bioweapons program contributed to the proliferation of Lyme disease.”
The ordeal underscores the national security threat posed by laboratory pathogen manipulation.
Rep. Smith, who is Co-Chair of the Congressional Lyme and Tick-Borne Disease Caucus, had offered similar amendments—one in 2019 and the other in 2021—which passed the House, but failed in the Senate.
The successful addition of the amendment follows FDA Chief Dr. Marty Makary’s statements during a November podcast, in which Makary expressed his belief that Lyme disease was created in U.S. military Lab 257 on Plum Island, New York.
A Thursday press release from Smith’s office reads:
A critical amendment authored by Rep. Chris Smith (R-NJ) to investigate whether the U.S. military weaponized ticks with Lyme disease has been included in the National Defense Authorization Act for Fiscal Year 2026 (FY26 NDAA) (S. 1071), which has cleared the U.S. House of Representatives, headed to the Senate, and is expected to be signed by President Trump upon its final passage.
Smith’s amendment—now Sec. 1068 of the bill—directs the Government Accountability Office (GAO)—the Congressional “watchdog”—to investigate the Cold War-era Department of Defense (Department of War) bioweapons program and determine whether they ever used ticks as hosts or delivery mechanisms for biological warfare agents.
In the press release, Smith emphasized that “New Jersey has one of the highest Lyme rates in the United States—the disease is present in all 21 counties.”
“The pervasive presence of Lyme disease in New Jersey not only carries concerns for civilians, but also for the military personnel stationed in the state—especially and including those serving at Joint Base McGuire-Dix-Lakehurst, part of which is located within my congressional district,” the republican added.
The press release explained that Smith’s amendments were inspired by Kris Newby’s book, Bitten: The Secret History of Lyme Disease and Biological Weapons.
The book includes interviews with Dr. Willy Burgdorfer, the federal researcher and U.S. bioweapons specialist credited with discovering Lyme disease.
Dr. Burgdorfer has revealed that “he and other bio-weapons specialists injected ticks with pathogens in order to cause severe disability, disease, and even death to potential enemies in unsuspecting ways.”
Smith’s amendment in the NDAA would compel the Comptroller General of the United States “to conduct an exhaustive review of research conducted by the military, the National Institutes of Health (NIH), the U.S. Department of Agriculture (USDA), and other federal agencies between the period of January 1, 1945 and December 31, 1972, regarding experiments involving Spirochaetales and Rickettsiales—two forms of tick-borne bacteria.”
Smith says we are now “one step closer to finally determining whether the U.S. government’s bioweapons program contributed to the proliferation of Lyme disease.”
“The hundreds of thousands of New Jerseyans suffering from Lyme disease—in addition to the millions across the United States—deserve to know the truth about the origins of their illness. An enhanced understanding of how Lyme came to be will only assist in finding a cure for this debilitating disease,” said Smith.
Rep. Smith’s amendment reads:
SEC. 1068. GAO REVIEW AND REPORT ON BIOLOGICAL WEAPONS EXPERIMENTS ON AND IN RELATION TO TICKS, TICK-BORNE DISEASE.
(a) REVIEW.— The Comptroller General of the United States shall, to the extent practicable, conduct a review of research conducted during the period beginning on January 1, 1945, and ending on December 31, 1972, by the Department of Defense, including by the Department of Defense in consultation with the National Institutes of Health, the Department of Agriculture, or any other Federal department or agency on—
(1) the use of ticks as hosts or delivery mechanisms for biological warfare agents, including experiments involving Spirochaetales or Rickettsiales; and
(2) any efforts to improve the effectiveness and viability of Spirochaetales or Rickettsiales as biological weapons through combination with other diseases or viruses.
(b) LOCATION OF RESEARCH.— In conducting the review under subsection (a), the Comptroller General shall review research conducted at facilities located inside the United States and, if feasible, facilities located outside the United States, including laboratories and field work locations.
(c) INFORMATION TO BE REVIEWED.—
(1) CLASSIFIED INFORMATION.— In conducting the review under subsection (a), the Comptroller General shall review any relevant classified information.
(2) MATTERS FOR REVIEW.— In conducting the review under subsection (a), the Comptroller General shall review, among other sources, the following:
(A) Technical Reports related to The Summary of Major Events and Problems, US Army Chemical Corps, FY 1951–FY 1969.
(B) Site Holding: CB DT DW 48158
Title: Virus and Rickettsia Waste Disposal Study.
Technical Report No. 103, January 1969.
Corp Author Name: Fort Detrick, Frederick, MD.
Report Number: SMUFD-TR-103.
Publish Date: 1969-01-01.(C) Site Holding: CB DT DW 60538
Title: A Plaque Assay System for Several Species of Rickettsia.
Corp Author Name: Fort Detrick, Frederick, MD.
Report Number: SMUFD-TM-538.
Publish Date: 1969-06-01.(D) Site Holding: CB DW 531493
Title: Progress Report for Ecology and Epidemiology and Biological Field Test Technology, Third Quarter FY 1967.
Corp Author Name: Army Dugway Proving Ground, UT.
Publish Date: 1967-05-08.(E) Any relevant scientific research on the history of Lyme disease in the United States.
(d) REPORT.—
(1) IN GENERAL.— Not later than two years after the date of the enactment of this Act, the Comptroller General shall submit to the Committees on Armed Services of the House of Representatives or the Senate a report that includes the following:
(A) A list of the research projects reviewed under subsection (a) and an assessment of the scope of such research.
(B) A finding by the Comptroller General as to whether such review could lead to a determination that any ticks used in such research were released outside of any facility (including any ticks that were released unintentionally).
(C) A finding by the Comptroller General as to whether such review could lead to a determination that any records related to such research were destroyed, and whether such destruction was intentional or unintentional.
(2) FORM OF REPORT.— The report required under paragraph (1) shall be submitted in unclassified form, but may contain a classified annex.
If the GAO does its job and follows the paper trail where it leads, this amendment may finally force the U.S. government to answer a question it has avoided for decades: whether a taxpayer-funded Cold War bioweapons program left millions of Americans paying the price with their health.
See more here substack.com
Some bold emphasis added